Study identifies skin microbiome as a factor in stem cell transplants

Skin microbiome identified as factor in stem cell transplants
Skin microbiome identified as factor in stem cell transplants. Credit: Kateryna Kon/Shutterstock

Organ damage occurs in up to 70% of patients in the first few months following stem cell transplant. The precise reasons for this potentially life-threatening reaction have long been the subject of scientific research.

Researchers led by Georg Stary from the Department of Dermatology at MedUni Vienna and Vienna General Hospital in collaboration with the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases have recently identified bacterial proliferation on the skin as a factor associated with the occurrence of the complication. The findings, recently published in the medical journal Leukemia, contribute to the research and development of new therapeutic approaches.

The researchers came to their findings by examining the skin of 50 patients, most of whom had undergone (SCT) for leukemia at the Department of Bone Marrow Transplantation at the Department of Internal Medicine I at MedUni Vienna and Vienna General Hospital. In the first few weeks or months after receiving the from the donor, a donor-versus-recipient reaction (, GVHD) occurred in some of the test subjects.

When the microorganisms on the skin () of those affected were analyzed in detail, the research team led by first author Nadine Bayer and study leader Georg Stary from MedUni Vienna and Vienna General Hospital found a drastic decrease in bacterial abundance.

"The reduction in proliferation was particularly pronounced in severe cases of GVHD—even before symptoms appeared," Georg Stary reported on key findings. At the same time, the scientists observed an increased occurrence in patients with GVHD of staphylococci on the skin, i.e. bacteria that can cause serious infections.

Reaction almost always involves the skin

Despite precise examinations of the stem cell donors' and recipients' tissue characteristics as well as preventive medication, GVHD occurs in approximately 30% of patients after sibling donations and in approximately 70% of patients after donations from unrelated donors. This reaction means that body cells are attacked as foreign by that are newly developed from the transplant, and organs are subsequently damaged.

The complication almost always affects the skin: the first symptoms are usually rashes, which, depending on the severity, can manifest themselves as slight redness or severely inflamed cutaneous changes with a detachment of the uppermost skin layer.

The fact that the composition of the gut microbiome influenced the clinical course after stem cell transplantation was already known to medical researchers. With the identification of the skin microbiome in GVHD, the scientists have another tool at their disposal with which to research and develop improved treatment measures.

"Follow-up studies will now show whether the change in the skin microbiome may contribute to the development of GVHD and whether new therapeutic approaches can be identified from the knowledge gained," says study leader Georg Stary, who also works at the CeMM Research Center for Molecular Medicine at the Austrian Academy of Sciences and at the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, with an eye toward the future.

More information: Nadine Bayer et al, Disturbances in microbial skin recolonization and cutaneous immune response following allogeneic stem cell transfer, Leukemia (2022). DOI: 10.1038/s41375-022-01712-z

Journal information: Leukemia

Citation: Study identifies skin microbiome as a factor in stem cell transplants (2022, October 13) retrieved 4 June 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Stem cell transplant: How skin-derived T cells can damage other organs


Feedback to editors